Nexstim Oyj (NXTMH) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.099x

Based on the latest financial reports, Nexstim Oyj (NXTMH) has a cash flow conversion efficiency ratio of 0.099x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€314.60K ≈ $367.80K USD) by net assets (€3.18 Million ≈ $3.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Nexstim Oyj stock price for real-time trading data and today's change.

Nexstim Oyj - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Nexstim Oyj's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Nexstim Oyj market cap and net worth for the company's overall valuation and market capitalisation.

Nexstim Oyj Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nexstim Oyj ranked by their cash flow conversion efficiency. Also see NXTMH total asset value for a full breakdown of the balance sheet.

Company Cash Flow Conversion Efficiency
Focus Point Holdings Bhd
KLSE:0157
0.604x
Nature and Environment Co. Ltd
KQ:043910
-0.061x
Outcrop Gold Corp
V:OCG
-0.200x
Elite Naturel Organik Gida Sanayi ve Ticaret AS
IS:ELITE
-0.007x
Financeira Alfa S.A. - Crédito Financiamento e Investimentos
SA:CRIV3
2.577x
Amanat Acquisition Corp Class A Ordinary Shares
NASDAQ:AMAN
N/A
European Residential Real Estate Investment Trust
TO:ERE-UN
0.032x
SM Culture & Contents Co. Ltd
KQ:048550
0.055x

Annual Cash Flow Conversion Efficiency for Nexstim Oyj (2012–2024)

The table below shows the annual cash flow conversion efficiency of Nexstim Oyj from 2012 to 2024. Review Nexstim Oyj (NXTMH) flexibility index to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €3.70 Million
≈ $4.33 Million
€1.88 Million
≈ $2.20 Million
0.508x +163.55%
2023-12-31 €2.84 Million
≈ $3.32 Million
€-2.27 Million
≈ $-2.65 Million
-0.800x -424.79%
2022-12-31 €4.07 Million
≈ $4.76 Million
€1.00 Million
≈ $1.17 Million
0.246x +130.21%
2021-12-31 €3.20 Million
≈ $3.74 Million
€-2.61 Million
≈ $-3.05 Million
-0.815x -143.95%
2020-12-31 €-1.47 Million
≈ $-1.72 Million
€-2.72 Million
≈ $-3.19 Million
1.855x -79.46%
2019-12-31 €-740.06K
≈ $-865.21K
€-6.68 Million
≈ $-7.81 Million
9.028x -57.10%
2018-12-31 €-294.27K
≈ $-344.04K
€-6.19 Million
≈ $-7.24 Million
21.043x +2250.25%
2017-12-31 €5.52 Million
≈ $6.45 Million
€-5.40 Million
≈ $-6.32 Million
-0.979x +39.34%
2016-12-31 €4.48 Million
≈ $5.24 Million
€-7.23 Million
≈ $-8.45 Million
-1.613x +40.48%
2015-12-31 €3.55 Million
≈ $4.14 Million
€-9.61 Million
≈ $-11.23 Million
-2.710x -199.06%
2014-12-31 €8.59 Million
≈ $10.04 Million
€-7.79 Million
≈ $-9.10 Million
-0.906x -154.19%
2013-12-31 €-2.38 Million
≈ $-2.78 Million
€-3.98 Million
≈ $-4.66 Million
1.672x +116.57%
2012-12-31 €304.81K
≈ $356.35K
€-3.08 Million
≈ $-3.60 Million
-10.090x --

About Nexstim Oyj

HE:NXTMH Finland Medical Devices
Market Cap
$80.28 Million
€68.67 Million EUR
Market Cap Rank
#20177 Global
#94 in Finland
Share Price
€9.52
Change (1 day)
-0.73%
52-Week Range
€8.14 - €16.40
All Time High
€705.72
About

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provi… Read more